ZYME Zymeworks Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
12:13
Aug 26
Aug 26
Morgan Stanley, Jefferies, Citigroup, and other firms raised price targets on over twenty.
Morgan Stanley, Jefferies, Citigroup, and other firms raised price targets on over twenty stocks including Affirm, Marvell, Moderna, and Snowflake, reflecting positive analyst sentiment across the board.
09:57
Jun 29
Jun 29
The tweet questions whether a takeover scenario is plausible for Zymeworks and Theravance.
The tweet questions whether a takeover scenario is plausible for Zymeworks and Theravance Biopharma, but lacks a clear directional position or trade call.
LOW
09:22
Jun 29
Jun 29
Zymeworks is in advanced talks to acquire Theravance Biopharma in a deal valued at 929 million.
Zymeworks is in advanced talks to acquire Theravance Biopharma in a deal valued at 929 million dollars.
About ZYME Analyst Coverage
Buzzberg tracks ZYME (Zymeworks Inc.) across 3 sources. 0 bullish vs 0 bearish calls from 3 analysts. Sentiment: evenly split. 3 total trade ideas tracked. Latest voices: DeItaone, seedy19tron, Bloomberg.